Prostate apoptosis response-4 mediates TGF-β-induced epithelial-to-mesenchymal transition

Cell Death and Disease

Volumn 5, Issue 2, 2014, Pages

  Chaudhry, P ^a   Fabi, F ^a   Singh, M ^a   Parent, S ^a   Leblanc, V ^a   Asselin, E ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

Author keywords

epithelial to mesenchymal transition (EMT); Par 4; TGF ; XIAP

Indexed keywords

CASPASE; DNA FRAGMENT; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; NEUTRALIZING ANTIBODY; PROTEINASE ACTIVATED RECEPTOR 4; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SNAIL; VIMENTIN; X LINKED INHIBITOR OF APOPTOSIS; ZINC FINGER PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; E BOX ELEMENT; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC TRANSFECTION; HELA CELL; HOMEOBOX; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; ENDOMETRIAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MICE; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UTERINE CERVICAL NEOPLASMS;

EID: 84896777092     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.7     Document Type: Article

References (49)

1. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454.
2. Zavadil J, Bitzer M, Liang D, Yang YC, Massimi A, Kneitz S et al. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci USA 2001; 98: 6686-6691.
3. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-142.
4. Zavadil J, Bottinger EP. TGF-beta and epithelial-To-mesenchymal transitions. Oncogene 2005; 24: 5764-5774.
5. Lamouille S, Derynck R. Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol 2007; 178: 437-451.
6. Penafuerte C, Galipeau J. TGF beta secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effect. Cancer Immunol Immunother 2008; 57: 1197-1206.
7. Maitra M, Cano CA, Garcia CK. Mutant surfactant A2 proteins associated with familial pulmonary fibrosis and lung cancer induce TGF-beta1 secretion. Proc Natl Acad Sci USA 2012; 109: 21064-21069.
8. Curran CS, Keely PJ. Breast tumor and stromal cell responses to TGF-beta and hypoxia in matrix deposition. Matrix Biol 2012; 32: 95-105.
9. Roberts AB, McCune BK, Sporn MB. TGF-beta: Regulation of extracellular matrix. Kidney Int 1992; 41: 557-559.
10. Kumawat K, Menzen MH, Bos IS, Baarsma HA, Borger P, Roth M et al. Noncanonical WNT-5 A signaling regulates TGF-beta-induced extracellular matrix production by airway smooth muscle cells. FASEB J 2012; 27: 1631-1643.
11. Goc A, Choudhary M, Byzova TV, Somanath PR. TGFbeta-And bleomycin-induced extracellular matrix synthesis is mediated through Akt and mammalian target of rapamycin (mTOR). J Cell Physiol 2011; 226: 3004-3013.
12. Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003; 3: 807-821.
13. Tang B, Vu M, Booker T, Santner SJ, Miller FR, Anver MR et al. TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest 2003; 112: 1116-1124.
14. Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001; 29: 117-129.
15. Kang Y, Massague J. Epithelial-mesenchymal transitions: Twist in development and metastasis. Cell 2004; 118: 277-279.
16. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7: 415-428.
17. Van Themsche C, Chaudhry P, Leblanc V, Parent S, Asselin E. XIAP gene expression and function is regulated by autocrine and paracrine TGF-beta signaling. Mol Cancer 2010; 9: 216.
18. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113: 685-700.
19. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003; 425: 577-584.
20. Singh M, Chaudhry P, Parent S, Asselin E. Ubiquitin-proteasomal degradation of COX-2 in TGF-beta stimulated human endometrial cells is mediated through endoplasmic reticulum mannosidase I. Endocrinology 2012; 153: 426-437.
21. El-Guendy N, Zhao Y, Gurumurthy S, Burikhanov R, Rangnekar VM. Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells. Mol Cell Biol 2003; 23: 5516-5525.
22. Zapata-Benavides P, Mendez-Vazquez JL, Gonzalez-Rocha TR, Zamora-Avila DE, Franco-Molina MA, Garza-Garza R et al. Expression of prostate apoptosis response (Par-4) is associated with progesterone receptor in breast cancer. Arch Med Res 2009; 40: 595-599.
23. Moreno-Bueno G, Fernandez-Marcos PJ, Collado M, Tendero MJ, Rodriguez-Pinilla SM, Garcia-Cao I et al. Inactivation of the candidate tumor suppressor par-4 in endometrial cancer. Cancer Res 2007; 67: 1927-1934.
24. Cook J, Krishnan S, Ananth S, Sells SF, Shi Y, Walther MM et al. Decreased expression of the pro-Apoptotic protein Par-4 in renal cell carcinoma. Oncogene 1999; 18: 1205-1208.
25. Nalca A, Qiu SG, El-Guendy N, Krishnan S, Rangnekar VM. Oncogenic Ras sensitizes cells to apoptosis by Par-4. J Biol Chem 1999; 274: 29976-29983.
26. Zhao Y, Rangnekar VM. Apoptosis and tumor resistance conferred by Par-4. Cancer Biol Ther 2008; 7: 1867-1874.
27. Van Themsche C, Mathieu I, Parent S, Asselin E. Transforming growth factor-beta3 increases the invasiveness of endometrial carcinoma cells through phosphatidylinositol 3-kinase-dependent up-regulation of X-linked inhibitor of apoptosis and protein kinase c-dependent induction of matrix metalloproteinase-9. J Biol Chem 2007; 282: 4794-4802.
28. Zeinoun Z, Teugels E, De Bleser PJ, Neyns B, Geerts A, De Greve J. Insufficient TGF-beta 1 production inactivates the autocrine growth suppressive circuit in human ovarian cancer cell lines. Anticancer Res 1999; 19: 413-420.
29. Yang L, Yang J, Venkateswarlu S, Ko T, Brattain MG. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells. J Cell Physiol 2001; 188: 383-393.
30. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 2002; 62: 65-74.
31. Saegusa M, Hashimura M, Kuwata T, Okayasu I. Transcriptional regulation of proapoptotic Par-4 by NF-kappaB/p65 and its function in controlling cell kinetics during early events in endometrial tumourigenesis. J Pathol 2010; 221: 26-36.
32. Lei X, Wang L, Yang J, Sun LZ. TGFbeta signaling supports survival and metastasis of endometrial cancer cells. Cancer Manag Res 2009; 2009: 15-24.
33. Szasz AM, Tokes AM, Micsinai M, Krenacs T, Jakab C, Lukacs L et al. Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis. Clin Exp Metastasis 2011; 28: 55-63.
34. Myal Y, Leygue E, Blanchard AA. Claudin 1 in breast tumorigenesis: Revelation of a possible novel 'claudin high' subset of breast cancers. J Biomed Biotechnol 2010; 2010: 956897.
35. Swisshelm K, Macek R, Kubbies M. Role of claudins in tumorigenesis. Adv Drug deliv Rev 2005; 57: 919-928.
36. Tokes AM, Kulka J, Paku S, Szik A, Paska C, Novak PK et al. Claudin-1,-3 and-4 proteins and mRNA expression in benign and malignant breast lesions: A research study. Breast Cancer Res 2005; 7: R296-R305.
37. Chaudhry P, Singh M, Parent S, Asselin E. Prostate apoptosis response 4 (Par-4), a novel substrate of caspase-3 during apoptosis activation. Mol Cell Biol 2012; 32: 826-839.
38. Koinuma D, Tsutsumi S, Kamimura N, Imamura T, Aburatani H, Miyazono K. Promoterwide analysis of Smad4 binding sites in human epithelial cells. Cancer Sci 2009; 100: 2133-2142.
39. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B et al. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1998; 1: 611-617.
40. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-Type 1 gene. EMBO J 1998; 17: 3091-3100.
41. Kim J, Johnson K, Chen HJ, Carroll S, Laughon A. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 1997; 388: 304-308.
42. Labbe E, Silvestri C, Hoodless PA,Wrana JL, Attisano L. Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2. Mol Cell 1998; 2: 109-120.
43. Massague J, Seoane J, Wotton D. Smad transcription factors. Genes Dev 2005; 19: 2783-2810.
44. Garcia-Cao I, Lafuente MJ, Criado LM, Diaz-Meco MT, Serrano M, Moscat J. Genetic inactivation of Par4 results in hyperactivation of NF-kappaB and impairment of JNK and p38. EMBO Rep 2003; 4: 307-312.
45. Martinez-Estrada OM, Lettice LA, Essafi A, Guadix JA, Slight J, Velecela V et al. Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin. Nat Genet 2010; 42: 89-93.
46. Dhasarathy A, Phadke D, Mav D, Shah RR, Wade PA. The transcription factors Snail and Slug activate the transforming growth factor-beta signaling pathway in breast cancer. PLoS ONE 2011; 6: E26514.
47. Dhasarathy A, Kajita M, Wade PA. The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-Alpha. Mol Endocrinol 2007; 21: 2907-2918.
48. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010; 12: R68.
49. Chapdelaine P, Kang J, Boucher-Kovalik S, Caron N, Tremblay JP, Fortier MA. Decidualization and maintenance of a functional prostaglandin system in human endometrial cell lines following transformation with SV40 large T antigen. Mol Hum Reprod 2006; 12: 309-319.